Market closed
GlucoTrack Inc./$GCTK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
Ticker
$GCTK
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
11
Website
GlucoTrack Inc. Metrics
BasicAdvanced
$4.1M
-
-$68.44
0.02
-
Price and volume
Market cap
$4.1M
Beta
0.02
52-week high
$0.51
52-week low
$0.13
Average daily volume
6.3M
Financial strength
Current ratio
4.524
Quick ratio
4.405
Long term debt to equity
-1.816
Total debt to equity
-2.054
Interest coverage (TTM)
-24.95%
Management effectiveness
Return on assets (TTM)
-167.79%
Return on equity (TTM)
461.02%
Valuation
Price to book
-0.01
Price to tangible book (TTM)
-0.01
Price to free cash flow (TTM)
-0.004
Growth
Earnings per share change (TTM)
78.68%
3-year earnings per share growth (CAGR)
37.51%
GlucoTrack Inc. News
AllArticlesVideos
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
GlobeNewsWire·4 days ago
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
GlobeNewsWire·2 weeks ago
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for GlucoTrack Inc. stock?
GlucoTrack Inc. (GCTK) has a market cap of $4.1M as of April 20, 2025.
What is the P/E ratio for GlucoTrack Inc. stock?
The price to earnings (P/E) ratio for GlucoTrack Inc. (GCTK) stock is 0 as of April 20, 2025.
Does GlucoTrack Inc. stock pay dividends?
No, GlucoTrack Inc. (GCTK) stock does not pay dividends to its shareholders as of April 20, 2025.
When is the next GlucoTrack Inc. dividend payment date?
GlucoTrack Inc. (GCTK) stock does not pay dividends to its shareholders.
What is the beta indicator for GlucoTrack Inc.?
GlucoTrack Inc. (GCTK) has a beta rating of 0.02. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.